BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26083247)

  • 1. Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.
    Persson M; Elfström KM; Olsson SE; Dillner J; Andersson S
    PLoS One; 2015; 10(6):e0127444. PubMed ID: 26083247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL).
    Frega A; Pavone M; Sesti F; Leone C; Bianchi P; Cozza G; Colombrino C; Lukic A; Marziani R; De Sanctis L; Delli Carpini G; Caserta D; Ciavattini A
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
    Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
    Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
    Gu L; Hong Z; Gao H; Qiu L; Di W
    Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital.
    Lertvutivivat S; Chanthasenanont A; Chanthasenanont A; Muangto T; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4353-4356. PubMed ID: 27797243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 8. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.
    Ryu KJ; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    Diagn Cytopathol; 2016 Dec; 44(12):959-963. PubMed ID: 27714942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
    Johansson H; Bjelkenkrantz K; Darlin L; Dilllner J; Forslund O
    PLoS One; 2015; 10(4):e0124460. PubMed ID: 25893988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An automated quantitative DNA image cytometry system detects abnormal cells in cervical cytology with high sensitivity.
    Wong OG; Ho MW; Tsun OK; Ng AK; Tsui EY; Chow JN; Ip PP; Cheung AN
    Cytopathology; 2018 Jun; 29(3):267-274. PubMed ID: 29578257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
    Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.
    Siebers AG; van der Linden H; Vedder JEM; Bekkers RLM; Melchers WLG; Bulten J
    Cytopathology; 2018 Jun; 29(3):275-280. PubMed ID: 29575519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
    Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
    Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
    Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High risk HPV testing in the triage of repeat ASC-US and LSIL.
    Veijalainen O; Tuomisaari S; Luukkaala T; Mäenpää J
    Acta Obstet Gynecol Scand; 2015 Sep; 94(9):931-6. PubMed ID: 26053676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.